IP Library Patent Application 13180443
Patent Application
App. No. 13/180,443

Focal Ablation Assembly

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/180,443
Abstract

A focal ablation assembly, used with an endoscope comprising an endoscopic tube, comprises a cap and a cryogenic catheter placeable within the endoscopic tube channel. The cryogenic catheter defines a catheter lumen and has a distal end placeable at the endoscopic tube distal end. The cap is mountable to at least one of the distal ends and extends distally of both. The cap comprises a material which substantially maintains its shape during use while not causing tissue trauma. The cap defines a limited area therapeutic region, which is a chosen one of an open therapeutic region and a covered, effectively thermally transparent therapeutic region providing effectively no thermal insulation. In some examples the assembly includes a delivery catheter extending along the channel with a distal portion fluidly coupled to the cap volume, whereby refrigerant can be introduced into the cap volume and towards the therapeutic region by the delivery catheter.

Claims (40)

1 . A focal ablation assembly, for use with an endoscope comprising an endoscopic tube having proximal and distal ends and defining a channel extending between the proximal and distal ends, the focal ablation assembly comprising:

a cryogenic catheter placeable within the channel, the cryogenic catheter defining a catheter lumen and having a distal end placeable at the distal end of the endoscopic tube;

a cap mountable to at least one of the distal end of the endoscopic tube and the distal end of the cryogenic catheter, the cap extending distally of both of the distal ends;

the cap comprising a material which substantially maintains its shape during use while not causing tissue trauma;

the cap defining a limited area therapeutic region;

the cap defining a cap volume defined by a wall of the cap and the therapeutic region; and

the therapeutic region being a chosen one of:

an open therapeutic region; and

a covered, optically transparent therapeutic region providing effectively no thermal insulation.

2 . The assembly according to claim 1 , wherein the cap is made of a flexible, soft polymer material.

3 . The assembly according to claim 1 , wherein the cap is made of at least one of polyvinyl chloride and polyurethane.

4 . The assembly according to claim 1 , wherein the cap has a distal end and the therapeutic region is at the distal end of the cap.

5 . The assembly according to claim 1 , wherein the cap has a sidewall and the therapeutic region is at the sidewall.

6 . The assembly according to claim 1 , wherein the therapeutic region is the covered therapeutic region, the covered therapeutic region having a flat shape.

7 . The assembly according to claim 1 , wherein the therapeutic region is the covered therapeutic region, the covered therapeutic region having a convex shape.

8 . The assembly according to claim 1 , wherein the therapeutic region is the covered therapeutic region, the covered therapeutic region being covered by a flexible, tissue-conformable material.

9 . The assembly according to claim 1 , wherein the therapeutic region is the covered therapeutic region, the covered therapeutic region being covered by an elastomeric material.

10 . The assembly according to claim 1 , wherein the endoscopic tube has a centerline and the therapeutic region is oriented oblique to the centerline.

11 . The assembly according to claim 1 , wherein the therapeutic region is generally elliptical.

12 . The assembly according to claim 1 , wherein the therapeutic region has a cross-sectional area and the endoscopic tube has a cross-sectional area, the cross-sectional area of the therapeutic region being greater than the cross-sectional area of the endoscopic tube.

13 . The assembly according to claim 1 , further comprising a delivery catheter extending along the channel and having a distal portion fluidly coupled to the cap volume, whereby refrigerant can be introduced into the cap volume and towards the therapeutic region by the delivery catheter.

14 . The assembly according to claim 13 , wherein the delivery catheter extends through the cryogenic catheter.

15 . The assembly according to claim 14 , further comprising:

a balloon extending from the distal end of the cryogenic catheter within the therapeutic region so that the refrigerant can be introduced into the balloon within the cap volume by the delivery catheter; and

an exhaust lumen defined by the catheter lumen.

16 . The assembly according to claim 13 , wherein the distal portion of the delivery catheter is positioned with an exit opening positioned within the cap volume.

17 . The assembly according to claim 13 , further comprising an exhaust lumen defined by at least one of (1) the channel of the endoscopic tube, and (2) the catheter lumen.

18 . The assembly according to claim 13 , wherein the distal portion of the refrigerant delivery catheter has a single exit opening for the discharge of the refrigerant towards the therapeutic region.

19 . A focal ablation system comprising:

an endoscope comprising an endoscopic tube having proximal and distal ends and defining a channel extending between the proximal and distal ends;

a focal ablation assembly comprising a cryogenic catheter and a cap;

the cryogenic catheter located within the channel, the cryogenic catheter defining a catheter lumen and having a distal end at the distal end of the endoscopic tube;

the cap mounted to at least one of the distal end of the endoscopic tube and the distal end of the catheter, the cap extending distally of both of the distal ends;

the cap defining a fixed-area therapeutic region;

the cap defining a volume defined by a wall of the cap and the therapeutic region; and

the therapeutic region being a chosen one of:

an open therapeutic region; and

a optically thermally transparent therapeutic region providing effectively no thermal insulation.

20 . The system according to claim 19 , further comprising a delivery catheter extending along the channel and having a distal portion fluidly coupled to the cap volume, whereby refrigerant can be introduced into the cap volume and towards the therapeutic region by the delivery catheter.

21 . The system according to claim 20 , further comprising an exhaust lumen defined by at least one of (1) the channel of the endoscopic tube, and (2) the catheter lumen.

Assignments (2)
MERGER Recorded Jul 13, 2018
From: C2 THERAPEUTICS, INC.
To: PENTAX OF AMERICA, INC.
Reel/Frame 046343/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2011
From: WU, PATRICK P.; ICO, CESAR A.; WILLIAMS, RICHARD S.
To: C2 THERAPEUTICS, INC.
Reel/Frame 026614/0306 →